	US 11,813,317 B2
	Method for preventing or treating metabolic disorder
Ruey-Hwa Chen, Taipei (TW); Yu-Hsuan Chen, Taipei (TW); Tzu-Yu Huang, Taipei (TW); Wen-Hsin Li, Taipei (TW); Ting-Fen Tsai, Taipei (TW); and Zhao-Qing Shen, Taipei (TW)
Assigned to Academia Sinica, Taipei (TW); and National Yang Ming Chiao Tung University, Taipei (TW)
Filed by Academia Sinica, Taipei (TW); and National Yang Ming Chiao Tung University, Taipei (TW)
Filed on Dec. 2, 2021, as Appl. No. 17/540,289.
Claims priority of provisional application 63/121,306, filed on Dec. 4, 2020.
Prior Publication US 2022/0175895 A1, Jun. 9, 2022
Int. Cl. A61P 3/00 (2006.01); C12N 15/86 (2006.01); A61K 38/48 (2006.01); A61P 3/04 (2006.01); A61K 45/06 (2006.01); C12N 9/48 (2006.01)

CPC A61K 38/4813 (2013.01) [A61K 45/06 (2013.01); A61P 3/04 (2018.01); C12N 9/485 (2013.01); C12N 15/86 (2013.01); C12Y 304/19012 (2013.01); C12N 2750/14111 (2013.01)]

16 Claims

1. A method for treating a fatty liver disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a viral vector comprising a nucleic acid encoding tumor-necrosis factor receptor-associated factor (TRAF)-binding protein domain (TRABID) protein.